Related Experiment Videos
Effect of dopamine on hypoxic-hypercapnic interaction in humans
Anesthesia and Analgesia
|July 1, 1987
Summary
Intravenous dopamine significantly reduces the body's ventilatory response to both low oxygen (hypoxia) and high carbon dioxide (hypercapnia) levels. However, it preserves the increased breathing drive caused by high carbon dioxide when oxygen is low.
Area of Science:
- Physiology
- Respiratory Regulation
- Pharmacology
Background:
- The chemical regulation of ventilation is crucial for maintaining blood gas homeostasis.
- Dopamine, a neurotransmitter and hormone, is known to influence various physiological systems, including cardiovascular and renal functions.
- Its specific effects on the chemical control of breathing, particularly under conditions of hypoxia and hypercapnia, require detailed investigation.
Purpose of the Study:
- To investigate the impact of intravenous dopamine administration on the ventilatory responses to hypercapnic hypoxia in healthy humans.
- To quantify the effects of dopamine on hypoxic ventilatory sensitivity and its interaction with varying levels of carbon dioxide tension.
Main Methods:
- Six healthy subjects received intravenous dopamine at a dose of 3 micrograms X kg-1 X min-1.
- Ventilatory responses were assessed during two hypoxic challenges under three different levels of carbon dioxide (eucapnia, moderate hypercapnia, and higher hypercapnia).
- Measurements included minute exhaled ventilation (VE), arterial hemoglobin saturation (SaO2), and end-tidal partial pressures of oxygen (PETO2) and carbon dioxide (PETCO2).
Main Results:
- Dopamine administration resulted in a significant reduction in hypoxic ventilatory sensitivity across all tested carbon dioxide levels (77% reduction during eucapnia, 39.5% at 46 mm Hg PETCO2, and 38% at 50 mm Hg PETCO2).
- Dopamine also decreased normoxic ventilation at all carbon dioxide levels, indicating a depression of the baseline ventilatory drive.
- The reduction in ventilation was more pronounced during hypercapnia (25.7% decrease) compared to eucapnia (12% decrease), suggesting dopamine depresses the normoxic ventilatory response to carbon dioxide.
Conclusions:
- Intravenous dopamine administration markedly attenuates the ventilatory response to both hypoxia and hypercapnia in healthy individuals.
- Despite reducing overall ventilation, dopamine does not abolish the potentiating effect of hypercapnia on the hypoxic ventilatory drive.
- These findings highlight dopamine's role as a respiratory depressant, particularly affecting chemoreceptor sensitivity to changes in blood gases.